Orlistat (sold as Alli) is one effective over-the-counter weight loss aid that is also FDA-approved.

Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ETCompany ParticipantsBrian Luque - Head of Investor Relations ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

Vivani Chief Executive Officer Adam Mendelsohn, Ph.D., stated, "Our ongoing first-in-human study, LIBERATE-1, remains on track to deliver key data in mid-2025 with the aim of validating our ...

Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ETCompany ParticipantsLee Roth - President, Burns McClellan, ...

Ben Katz, chief executive officer of Happy Head, holds three degrees from the University of Pennsylvania, including an M.B.A.

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.

Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.

Medications like semaglutide and liraglutide may help to reduce the risk of heart attacks, strokes, and other major adverse ...